52 related articles for article (PubMed ID: 27421225)
1. The pathogenic mechanism of dysbindin-1B toxic aggregation: BLOC-1 and intercellular vesicle trafficking.
Yang W; Zhu C; Shen Y; Xu Q
Neuroscience; 2016 Oct; 333():78-91. PubMed ID: 27421225
[TBL] [Abstract][Full Text] [Related]
2. Dysbindin-containing complexes and their proposed functions in brain: from zero to (too) many in a decade.
Ghiani CA; Dell'Angelica EC
ASN Neuro; 2011 May; 3(2):. PubMed ID: 21504412
[TBL] [Abstract][Full Text] [Related]
3. The schizophrenia susceptibility factor dysbindin and its associated complex sort cargoes from cell bodies to the synapse.
Larimore J; Tornieri K; Ryder PV; Gokhale A; Zlatic SA; Craige B; Lee JD; Talbot K; Pare JF; Smith Y; Faundez V
Mol Biol Cell; 2011 Dec; 22(24):4854-67. PubMed ID: 21998198
[TBL] [Abstract][Full Text] [Related]
4. MeCP2 regulates the synaptic expression of a Dysbindin-BLOC-1 network component in mouse brain and human induced pluripotent stem cell-derived neurons.
Larimore J; Ryder PV; Kim KY; Ambrose LA; Chapleau C; Calfa G; Gross C; Bassell GJ; Pozzo-Miller L; Smith Y; Talbot K; Park IH; Faundez V
PLoS One; 2013; 8(6):e65069. PubMed ID: 23750231
[TBL] [Abstract][Full Text] [Related]
5. Synaptic dysbindin-1 reductions in schizophrenia occur in an isoform-specific manner indicating their subsynaptic location.
Talbot K; Louneva N; Cohen JW; Kazi H; Blake DJ; Arnold SE
PLoS One; 2011 Mar; 6(3):e16886. PubMed ID: 21390302
[TBL] [Abstract][Full Text] [Related]
6. Cell biology of the BLOC-1 complex subunit dysbindin, a schizophrenia susceptibility gene.
Mullin AP; Gokhale A; Larimore J; Faundez V
Mol Neurobiol; 2011 Aug; 44(1):53-64. PubMed ID: 21520000
[TBL] [Abstract][Full Text] [Related]
7. Neurobehavioral abnormalities in the dysbindin-1 mutant, sandy, on a C57BL/6J genetic background.
Cox MM; Tucker AM; Tang J; Talbot K; Richer DC; Yeh L; Arnold SE
Genes Brain Behav; 2009 Jun; 8(4):390-7. PubMed ID: 19220483
[TBL] [Abstract][Full Text] [Related]
8. Neuronal Activity-Induced Sterol Regulatory Element Binding Protein-1 (SREBP1) is Disrupted in Dysbindin-Null Mice-Potential Link to Cognitive Impairment in Schizophrenia.
Chen Y; Bang S; McMullen MF; Kazi H; Talbot K; Ho MX; Carlson G; Arnold SE; Ong WY; Kim SF
Mol Neurobiol; 2017 Apr; 54(3):1699-1709. PubMed ID: 26873854
[TBL] [Abstract][Full Text] [Related]
9. The schizophrenia susceptibility gene dysbindin controls synaptic homeostasis.
Dickman DK; Davis GW
Science; 2009 Nov; 326(5956):1127-30. PubMed ID: 19965435
[TBL] [Abstract][Full Text] [Related]
10. DISC1 causes associative memory and neurodevelopmental defects in fruit flies.
Furukubo-Tokunaga K; Kurita K; Honjo K; Pandey H; Ando T; Takayama K; Arai Y; Mochizuki H; Ando M; Kamiya A; Sawa A
Mol Psychiatry; 2016 Sep; 21(9):1232-43. PubMed ID: 26976042
[TBL] [Abstract][Full Text] [Related]
11. Loss of dysbindin-1 in mice impairs reward-based operant learning by increasing impulsive and compulsive behavior.
Carr GV; Jenkins KA; Weinberger DR; Papaleo F
Behav Brain Res; 2013 Mar; 241():173-84. PubMed ID: 23261874
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation of Specialized Delay/Interference-Dependent Working Memory Following Loss of Dysbindin-1A in Schizophrenia-Related Phenotypes.
Petit EI; Michalak Z; Cox R; O'Tuathaigh CM; Clarke N; Tighe O; Talbot K; Blake D; Joel J; Shaw A; Sheardown SA; Morrison AD; Wilson S; Shapland EM; Henshall DC; Kew JN; Kirby BP; Waddington JL
Neuropsychopharmacology; 2017 May; 42(6):1349-1360. PubMed ID: 27986973
[TBL] [Abstract][Full Text] [Related]
13. Dysbindin and Schizophrenia: it's dopamine and glutamate all over again.
Papaleo F; Weinberger DR
Biol Psychiatry; 2011 Jan; 69(1):2-4. PubMed ID: 21145442
[No Abstract] [Full Text] [Related]
14. Schizophrenia: the "BLOC" may be in the endosomes.
Ryder PV; Faundez V
Sci Signal; 2009 Oct; 2(93):pe66. PubMed ID: 19843956
[TBL] [Abstract][Full Text] [Related]
15. Expression of Concern: Synaptic Dysbindin-1 Reductions in Schizophrenia Occur in an Isoform-Specific Manner Indicating Their Subsynaptic Location.
PLOS ONE Editors
PLoS One; 2024; 19(3):e0301152. PubMed ID: 38507352
[No Abstract] [Full Text] [Related]
16. Protein Misfolding and Aggregation in the Brain: Common Pathogenetic Pathways in Neurodegenerative and Mental Disorders.
Ochneva A; Zorkina Y; Abramova O; Pavlova O; Ushakova V; Morozova A; Zubkov E; Pavlov K; Gurina O; Chekhonin V
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430976
[TBL] [Abstract][Full Text] [Related]
17. Genetic Effects of the Schizophrenia-Related Gene
Tao H; Zhou X; Chen J; Zhou H; Huang L; Cai Y; Fu J; Liu Z; Chen Y; Sun C; Zhao B; Zhong W; Li K
Front Genet; 2021; 12():553974. PubMed ID: 33679873
[TBL] [Abstract][Full Text] [Related]
18. Behavioral Tasks Evaluating Schizophrenia-like Symptoms in Animal Models: A Recent Update.
Ang MJ; Lee S; Kim JC; Kim SH; Moon C
Curr Neuropharmacol; 2021; 19(5):641-664. PubMed ID: 32798374
[TBL] [Abstract][Full Text] [Related]
19. Retinal biomarkers and pharmacological targets for Hermansky-Pudlak syndrome 7.
Romano GL; Platania CBM; Leggio GM; Torrisi SA; Giunta S; Salomone S; Purrello M; Ragusa M; Barbagallo C; Giblin FJ; Mastrogiacomo R; Managò F; Cammalleri M; Papaleo F; Drago F; Bucolo C
Sci Rep; 2020 Mar; 10(1):3972. PubMed ID: 32132582
[TBL] [Abstract][Full Text] [Related]
20. Developmental Genes and Regulatory Proteins, Domains of Cognitive Impairment in Schizophrenia Spectrum Psychosis and Implications for Antipsychotic Drug Discovery: The Example of Dysbindin-1 Isoforms and Beyond.
Waddington JL; Zhen X; O'Tuathaigh CMP
Front Pharmacol; 2019; 10():1638. PubMed ID: 32063853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
